1. Home
  2. PMAX vs INKT Comparison

PMAX vs INKT Comparison

Compare PMAX & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • INKT
  • Stock Information
  • Founded
  • PMAX 2019
  • INKT 2017
  • Country
  • PMAX Hong Kong
  • INKT United States
  • Employees
  • PMAX N/A
  • INKT N/A
  • Industry
  • PMAX
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • PMAX
  • INKT Health Care
  • Exchange
  • PMAX Nasdaq
  • INKT Nasdaq
  • Market Cap
  • PMAX 32.0M
  • INKT 36.7M
  • IPO Year
  • PMAX 2024
  • INKT 2021
  • Fundamental
  • Price
  • PMAX $0.42
  • INKT $9.38
  • Analyst Decision
  • PMAX
  • INKT Strong Buy
  • Analyst Count
  • PMAX 0
  • INKT 2
  • Target Price
  • PMAX N/A
  • INKT $6.50
  • AVG Volume (30 Days)
  • PMAX 4.4M
  • INKT 72.2K
  • Earning Date
  • PMAX 02-21-2025
  • INKT 03-20-2025
  • Dividend Yield
  • PMAX N/A
  • INKT N/A
  • EPS Growth
  • PMAX N/A
  • INKT N/A
  • EPS
  • PMAX 0.04
  • INKT N/A
  • Revenue
  • PMAX $5,970,263.00
  • INKT N/A
  • Revenue This Year
  • PMAX N/A
  • INKT N/A
  • Revenue Next Year
  • PMAX N/A
  • INKT N/A
  • P/E Ratio
  • PMAX $10.72
  • INKT N/A
  • Revenue Growth
  • PMAX 30.05
  • INKT N/A
  • 52 Week Low
  • PMAX $0.34
  • INKT $4.56
  • 52 Week High
  • PMAX $4.70
  • INKT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • INKT 51.78
  • Support Level
  • PMAX N/A
  • INKT $7.32
  • Resistance Level
  • PMAX N/A
  • INKT $13.79
  • Average True Range (ATR)
  • PMAX 0.00
  • INKT 2.00
  • MACD
  • PMAX 0.00
  • INKT 0.05
  • Stochastic Oscillator
  • PMAX 0.00
  • INKT 52.22

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: